ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

NCT00936676 · clinicaltrials.gov ↗

COMPLETED

Status

684

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: rasagiline mesylate

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]
[object Object]